Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 24, 2025 10:00 ET | Source: Halda Therapeutics

Halda Therapeutics Announces First-in-Human Results for HLD-0915, an Oral RIPTAC™ Therapeutic Demonstrating Encouraging Safety and Anti-Tumor Activity in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Anti-tumor activity was observed in heavily pretreated mCRPC patients across all dose cohorts; in 22 patients who completed at least 2 cycles of therapy, 59% achieved PSA50 response and 32% achieved...
September 24, 2025 08:45 ET | Source: Akari Therapeutics Plc

Akari Therapeutics’ Preclinical Data Demonstrates the Potential of its Novel ADC Spliceosome Modulating Payload, PH1

Data highlights ability of Akari’s ADC payload, PH1, to suppress the levels of the AR-V7 receptor that is responsible for driving hormone refractory prostate cancer progression No current therapies...
September 09, 2025 06:00 ET | Source: Biosplice Therapeutics, Inc.

Biosplice Therapeutics Announces First Patient Dosed in NCI-Sponsored Clinical Trial of Cirtuvivint in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Multicenter study sponsored by the National Cancer Institute
August 28, 2025 09:00 ET | Source: Berry Street

Berry Street Adds Veteran Commercial, Product, and Clinical Nutrition Experts to Leadership Team

NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Berry Street, an AI-powered nutrition therapy platform, today announced three strategic appointments: Richard Fu has joined as the company’s first Chief...
July 01, 2025 09:00 ET | Source: SNS Insider pvt ltd

Fusion Splicer Market Size to Surpass USD 1212.5 Million by 2032, Driven by Increasing Demand for High-Speed Fiber Optic Networks | SNS Insider

Austin, July 01, 2025 (GLOBE NEWSWIRE) -- Fusion Splicer Market Size & Growth Insights: According to the SNS Insider Report, “The Fusion Splicer Market was valued at USD 798.3 Million in 2023...
June 17, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Oligonucleotides Clinical Trial Pipeline Analysis Demonstrates 280+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

New York, USA, June 17, 2025 (GLOBE NEWSWIRE) -- Oligonucleotides Clinical Trial Pipeline Analysis Demonstrates 280+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm,...
June 03, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Huntington’s Disease Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping the Future of Dopamine Receptor Antagonists Therapeutics | DelveInsight

New York, USA, June 03, 2025 (GLOBE NEWSWIRE) -- Huntington’s Disease Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping the Future of Dopamine Receptor Antagonists Therapeutics |...
May 27, 2025 09:18 ET | Source: iMemories

iMemories Reviews: Is It Worth the Hype or Just A Scam

New york, May 27, 2025 (GLOBE NEWSWIRE) -- Many priceless memories are stored in old family films and photo albums. A grandmother's giggle captured on camera, a faded wedding day snapshot, or...
April 29, 2025 10:00 ET | Source: Kriya Therapeutics, Inc.

Kriya Announces Thirteen Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2025

– Kriya’s platform includes fully integrated best-in-class manufacturing and research capabilities to support parallel advancement of a broad pipeline of gene therapies – – Current pipeline of gene...
April 25, 2025 13:17 ET | Source: Pyxis Oncology

Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC

Gene signatures associated with increased efficacy of micvotabart pelidotin (MICVO) due to greater linker cleavage were identified based on differential gene expression analysis of PDX...